Latest News and Press Releases
Want to stay updated on the latest news?
-
Company announcement – No. 9 / 2021 Zealand Pharma Hosts Conference Call on March 11 at 4 pm CET (10am ET) to Present Full Year Results for 2020 Copenhagen, DK March 3, 2021 – Zealand Pharma...
-
Company announcement – No. 8 / 2021 Copenhagen, DK February 23, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and...
-
Press Release – No. 7 / 2021 Copenhagen, DK and Boston, MA, February 9, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and...
-
Company announcement – No. 6/ 2021 Copenhagen, DK and Boston, MA, U.S., February 8, 2021 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20045078) a biotechnology company focused on the...
-
Company announcement – No. 5 / 2021 Zealand Pharma to Host R&D Day on March 5, 2021 Zealand Pharma’s virtual Research & Development Day on March 5, 2021 will highlight progress...
-
Company announcement – No. 4 / 2021 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS...
-
Company announcement – No. 3 / 2021 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS...
-
Company announcement – No. 2 / 2021 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY...
-
Company announcement – No. 1 / 2021 Net operating expenses in 2020 are expected to be above the previously guided range of DKK 950-1,000 million by approximately 5-10%. Copenhagen, January 22, 2021...
-
Company announcement – No. 64 / 2020 Copenhagen, December 31, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the...